Cyteir Leadership 2018-10-15T11:37:39+00:00

Cyteir Leadership


Markus Renschler, MD
Markus Renschler, MDPresident and Chief Executive Officer
Kevin Mills, PhD
Kevin Mills, PhDFounder and Chief Scientific Officer
Jean-Marc Lapierre, PhD
Jean-Marc Lapierre, PhDVice President of Chemistry
Darryl Patrick, PhD, DVM
Darryl Patrick, PhD, DVMHead of Preclinical Research and Development

“It is with patients in the forefront of our minds that we work diligently to develop novel gain of function synthetic lethal therapies”

Melinda Anne Lynch Day, PhD – Principal Scientist, Cyteir Therapeutics, Inc.